# CoBX Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cobx-bio

- Headquarters: Seoul, South Korea
- Website: www.cobxbio.com/
- Total disclosed funding: $19M
- Latest round: Series B (Jun 30, 2026)
- Investors on record: 10

## About

Based in Seoul, South Korea, and founded in 2024, CoBX Bio, Inc. operates as a company that researches and develops covalent bond inhibitors and molecular adhesive degraders that can address shortcomings of current synthetic medications, including resistance and insufficient effectiveness, by forming stronger attachments to disease-related proteins. In June 2026, CoBX Bio, Inc. raised KRW 29 billion in series B funding from new investors Forest Ventures, Atinum Investment, Kiwoom Investment, and K2 Investment Partners. Returning investor Korea Investment Partners, Laplace Partners, Solid X, Solidus Investment, Company K Partners, and KB Investment also participated in this round.

CoBX Bio’s proprietary platform, RaPIDome, integrates chemical proteomics, molecular modeling, and AI to identify drug mechanisms and resistance pathways. Key pipelines include covalent inhibitors targeting Menin (a MEN1-derived protein) and molecular adhesive degraders aimed at GSPT1, a protein linked to cancer cell survival. These compounds are designed to offer enhanced efficacy and resistance mitigation. The company plans to use the September 2025 funds to support the development of Menin inhibitors and E3 ligase inhibitors.

## Funding rounds

- Series B, Jun 30, 2026, $19M — KB Investment, Atinum Investment, Korea Investment Partners, Solidus Investment, Company K Partners, Kiwoom Investment, K2 Investment Partners, Forest Ventures, Laplace Partners, Solid X

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series B
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series B
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series B
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series B
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series B
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Series B
- K2 Investment Partners (https://capitalatlas.ai/funds/k2-investment-partners) — Series B
- Forest Ventures (https://capitalatlas.ai/funds/forest-ventures) — Series B
- Laplace Partners (https://capitalatlas.ai/funds/laplace-partners) — Series B
- Solid X (https://capitalatlas.ai/funds/solid-x) — Series B
